KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Operating Leases (2019 - 2026)

CareDx's Operating Leases history spans 8 years, with the latest figure at $17.8 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 41.09% to $17.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.8 million, a 41.09% decrease, with the full-year FY2025 number at $19.7 million, down 11.61% from a year prior.
  • Operating Leases hit $17.8 million in Q1 2026 for CareDx, down from $19.7 million in the prior quarter.
  • Over the last five years, Operating Leases for CDNA hit a ceiling of $36.4 million in Q2 2023 and a floor of $16.1 million in Q2 2022.
  • Historically, Operating Leases has averaged $26.1 million across 5 years, with a median of $26.9 million in 2024.
  • Biggest five-year swings in Operating Leases: surged 126.07% in 2023 and later plummeted 41.09% in 2026.
  • Tracing CDNA's Operating Leases over 5 years: stood at $33.4 million in 2022, then decreased by 15.35% to $28.3 million in 2023, then dropped by 21.27% to $22.3 million in 2024, then dropped by 11.61% to $19.7 million in 2025, then fell by 9.36% to $17.8 million in 2026.
  • Business Quant data shows Operating Leases for CDNA at $17.8 million in Q1 2026, $19.7 million in Q4 2025, and $21.2 million in Q3 2025.